Skip to main content

Loading market ticker...

Akums Drugs & Pharma

Healthcare NSE:AKUMS

524.50INR
-10.75 ( -2.01%)

Last update at May 29, 2026, 3:58 p.m.

Day Range

522.00543.00
LowHigh

52 Week Range

405.00 636.00
LowHigh

Fundamentals

  • Previous Close 535.25
  • Market Cap 68067.41M
  • Volume84,905
  • P/E Ratio 18.90
  • EBITDA 4648.01M
  • Revenue TTM 41260.50M
  • Revenue Per Share TTM 271.24
  • Gross Profit TTM 16408.25M
  • Diluted EPS TTM 22.31

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1427.60 15/05/26 15/05/26 Same Day Short Term Healthcare 0.17%
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly
Income before tax 3452.53M -452.78M 1502.97M -1931.97M
Net income 3381.76M -40.35M 948.55M -2525.36M
Total Revenue 40710.93M 40196.82M 34747.64M 36468.34M
Gross Profit 16053.56M 14374.58M 11672.94M 12690.01M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total assets 41134.42M 35163.65M 32665.27M 30690.48M
Intangible assets 83.03M 68.85M 59.00M 56.40M
Other current assets 22.41M 66.08M 51.03M 11.04M
Deferred long term liab - - - -
Non current assets other - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Change in Cash -98.59M 598.23M -35.31M 330.72M
Operating Cash 4651.96M 4982.59M 1766.31M 318.54M
Free Cash Flow 1928.84M 1868.51M -1521.62M -2257.28M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
AKUMS
Akums Drugs & Pharma 		-10.75 -2.01% 524.50 68067.41 18.90
SUNPHARMA
Sun Pharmaceutical Industries Limited 		-45.10 -2.45% 1799.20 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-130.50 -1.92% 6667.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-127.00 -2.80% 4410.80 1362716.66 63.48
CIPLA
Cipla Limited 		-17.20 -1.21% 1401.00 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.